Skip to main content
Clinical Trials/NCT02539004
NCT02539004
Completed
Not Applicable

Ultrasound Non-contrast Computed Tomography Real-time Fusion for Urinary Stones Follow up

Rambam Health Care Campus1 site in 1 country70 target enrollmentJune 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Urolithiasis
Sponsor
Rambam Health Care Campus
Enrollment
70
Locations
1
Primary Endpoint
US identification of ureteral stone seen on NCCT
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Urolithiasis is a universal problem, a large part of patients will be affected by multiple stones throughout their lifetime, with estimated recurrence rates of 75% within 20 years. The high recurrence rate requires an increasing amount of imaging follow-up. US-NCCT real-time fusion (Fusion) enables lesion assessment and follow up using both modalities as reference for each other. Our study proposes a novel approach for short term follow up of patients using Fusion instead of repeat NCCT exams.

the goal of the study is to create an initial proof of concept that Fusion is effective for follow up of known urinary stones.

the study is a prospective study on Patients with an obstructing ureteral stone found on a NCCT. Patients will undergo Fusion (using General Electric Logiq E9) after NCCT. The primary endpoint was the ability to locate the ureteral stone using US with guidance of the NCCT as a "Road Map".

Registry
clinicaltrials.gov
Start Date
June 2015
End Date
October 26, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • NCCT within 3 months prior to the US study with proved Urolithiasis

Exclusion Criteria

  • Inability to perform a US study.
  • Pacemaker

Outcomes

Primary Outcomes

US identification of ureteral stone seen on NCCT

Time Frame: up to 3 months after NCCT

Study Sites (1)

Loading locations...

Similar Trials